Insider Transactions in Q4 2024 at Homology Medicines, Inc. (FIXX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2024
|
Shelia M. Violette Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+20.08%
|
$42,000
$7.29 P/Share
|
|
Oct 11
2024
|
Shelia M. Violette Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,574
+20.38%
|
$13,722
$3.12 P/Share
|
|
Oct 08
2024
|
Shelia M. Violette Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,300
+50.0%
|
$39,900
$3.12 P/Share
|